Effect of short-acting beta blocker on the cardiac recovery after cardiopulmonary bypass

Journal of Cardiothoracic Surgery

Volumn 6, Issue 1, 2011, Pages

  Sun, Jie ^a   Ding, Zhengnian ^a   Qian, Yanning ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Arrhythmia; Cardiopulmonary bypass; Esmolol; Heart rate; Mitral valve replacement

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; PROPANOLAMINE DERIVATIVE;

ANALYSIS OF VARIANCE; ARTICLE; CARDIOPULMONARY BYPASS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HEART VALVE REPLACEMENT; HUMAN; MALE; METHODOLOGY; MITRAL VALVE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC HEART DISEASE;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; CARDIOPULMONARY BYPASS; CHI-SQUARE DISTRIBUTION; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MITRAL VALVE; POSTOPERATIVE COMPLICATIONS; PROPANOLAMINES; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RHEUMATIC HEART DISEASE;

EID: 80051793556     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-6-99     Document Type: Article

References (16)

1. Booth JV, Spahn DR, McRae RL, Chesnut LC, El-Moalem H, Atwell DM, Leone BJ, Schwinn DA. Esmolol improves left ventricular function via enhanced beta-adrenergic receptor signaling in a canine model of coronary revascularization. Anesthesilogy 2002, 97:162-169.
2. Cork RC, Azari DM, McQueen KA, Aufderheide S, Mitchell M, Naraghi M. Effect of esmolol given during cardiopulmonary bypass on fractional area of contraction from transesophageal echocardiography. Anesth Analg 1995, 81:219-224.
3. Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM. Kinetics of esmolol, an ultra-short-acting β-blocker, and of its major metabolite. Clin Pharmacol Ther 1983, 34:427-434. 10.1038/clpt.1983.193, 6617063.
4. Bessho R, Chambers DJ. Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat. J Thorac Cardiovasc Surg 2002, 124:340-351. 10.1067/mtc.2002.121976, 12167795.
5. Scorsin M, Mebazaa A, Al Attar N, Medini B, Callebert J, Raffoul R, Ramadan R, Maillet JM, Ruffenach A, Simoneau F, Nataf P, Payen D, Lessana A. Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia. J Thorac Cardiovasc Surg 2003, 125:1022-1029. 10.1067/mtc.2003.175, 12771874.
6. Fallouh HB, Bardswell SC, McLatchie LM, Shattock MJ, Chambers DJ, Kentish JC. Esmolol cardioplegia: the cellular mechanism of diastolic arrest. Cardiovasc Res 2010, 87:552-560. 10.1093/cvr/cvq058, 20176816.
7. Fannelop T, Dahle GO, Matre K, Moen CA, Mongstad A, Eliassen F, Segadal L, Grong K. Esmolol before 80 min of cardiac arrest with oxygenated cold blood cardioplegia alleviates systolic dysfunction. An experimental study in pigs. Eur J Cardiothorac Surg 2008, 33:9-17. 10.1016/j.ejcts.2007.10.011, 18032058.
8. Bassiakou E, Xanthos T, Papadimitriou L. The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation. Eur J Pharmacol 2009, 616:1-6. 10.1016/j.ejphar.2009.06.019, 19555681.
9. Jingjun L, Yan Z, Dongdong Z, Guosheng L, Mingwei B. Effect and mechanism of esmolol given during cardiopulmonary resuscitation in a porcine ventricular fibrillation model. Resuscitation 2009, 80:1052-1059. 10.1016/j.resuscitation.2009.06.003, 19581034.
10. Deng CY, Lin SG, Zhang WC, Kuang SJ, Qian WM, Wu SL, Shan ZX, Yang M, Yu XY. Esmolol inhibits Na+ current in rat ventricular myocytes. Methods Find Exp Clin Pharmacol 2006, 28:697-702. 10.1358/mf.2006.28.10.1037498, 17235414.
11. Killingsworth CR, Wei CC, Dell'Italia LJ, Ardell JL, Kingsley MA, Smith WM, Ideker RE, Walcott GP. Short-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation. Circulation 2004, 109:2469-2674. 10.1161/01.CIR.0000128040.43933.D3, 15123529.
12. Zangrillo A, Turi S, Crescenzi G, Oriani A, Distaso F, Monaco F, Bignami E, Landoni G. Esmolol reduces perioperative ischemia in cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2009, 23:625-632. 10.1053/j.jvca.2009.01.003, 19297196.
13. Chauhan S, Saxena N, Rao BH, Singh RS, Bhan A. A comparison of esmolol and diltiazem for heart rate control during coronary revascularisation on beating heart. Ann Card Anaesth 2000, 3:28-31.
14. Arar C, Colak A, Alagol A, Uzer SS, Ege T, Turan N, Duran E, Pamukcu Z. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. Eur J Anaesthesiol 2007, 24:826-831. 10.1017/S0265021507000865, 17583595.
15. Boldt J, Brosch C, Lehmann A, Suttner S, Isgro F. The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Anesth Analg 2004, 99:1009-1017. 10.1213/01.ANE.0000132969.88550.96, 15385341.
16. Iliodromitis EK, Tasouli A, Andreadou I, Bofilis E, Zoga A, Cokkinos P, Kremastinos DT. Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo. Eur J Pharmacol 2004, 499:163-169. 10.1016/j.ejphar.2004.07.093, 15363963.